Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +971 (0) 4 368 1644
  • GDPR
  • Journalists
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +971 (0) 4 368 1644 from 8 AM - 5:30 PM GMT

    • Contact
    • Contact

      +971 (0) 4 368 1644
      from 8 AM - 5:30 PM GMT

  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR

Fapon at Medlab Middle East 2024: Advancing Local Healthcare through IVD Technologies
  • Middle East - Arabic

1_Logo

News provided by

Fapon

07 Feb, 2024, 14:17 GMT

Share this article

Share toX

Share this article

Share toX

DONGGUAN, China, Feb. 7, 2024 /PRNewswire/ -- Fapon, a global leading life sciences company, is showcasing its comprehensive one-stop IVD solutions and sharing the latest industry insights with global IVD professionals at Medlab Middle East 2024 in Dubai, UAE, from Feb 5 to Feb 8. Dedicated to leveraging its cutting-edge technologies and vast industry experience, Fapon aims to support the growth of the local IVD industry, enhancing local healthcare services while strengthening its global diagnostics ecosystem.

Continue Reading
1
1

During the exhibition, Fapon will present extensive one-stop solutions, emphasizing on applications such as CLIA, NGS, and PCR. Additionally, it will introduce a diverse range of high-performance core raw materials for disease diagnostics, catering to various diagnostic needs in the region, including HIV, diabetes, gastrointestinal infections, HCV, and HBV. Utilizing its robust IVD technology foundation, Fapon seamlessly integrates raw materials, reagent services, and open instrument platforms into comprehensive one-stop solutions, providing a reliable, flexible, and integrated approach to meet diverse needs for the local IVD partners.

Highlighting its one-stop CLIA solution, Fapon's exhibition will nonetheless feature the latest ultra-high throughput CLIA system, Shine i8000/9000, which is widely recognized for its efficiency and speedy results. This addition, complementing the existing Shine i1000 and Shine i2000, completes Fapon's instrument portfolio, provides a comprehensive range of high, medium, and low-throughput CLIA instruments. This ensures a more extensive and flexible range of choices for its IVD partners.

Committed to empowering local IVD companies and boosting the development of the local healthcare industry in the Middle East, Fapon has established a strategic partnership with the China Innovation Center (C.I.C.) at Dubai Chambers in 2023. This collaboration aims to introduce Fapon's innovative technologies, products, and services in diagnostics and therapeutics for the medical advancement of the local healthcare industry.

Looking ahead, Fapon will remain rooted in the local market in the Middle East, strengthening collaborations with local partners and enhancing healthcare services for the local region.

About Fapon

Fapon is a global leading life sciences company dedicated to providing integrated solutions and services for diagnostics, biopharma and biotherapy. Integrating a one-stop solution on raw materials, reagents and innovative open instrument platforms, the Company has grown into a leading supplier in in-vitro diagnostics. Fapon boasts advanced innovations in therapeutics technologies and AI algorithm platforms with data insights that contribute to a better and healthier world. Supported by its strong global R&D, manufacturing, sales and service network, Fapon's products have established presence in 68 countries and regions, serving more than 2,500 business partners worldwide.

Follow us on LinkedIn (Fapon) or visit our website https://en.faponbiotech.com/

Photo - https://mma.prnewswire.com/media/2336397/1.jpg
Logo - https://mma.prnewswire.com/media/2305259/1_Logo.jpg

Modal title

Also from this source

Fapon at Medlab Middle East 2025: Advancing Local Diagnostic Industry through One-stop IVD Solutions

Fapon at Medlab Middle East 2025: Advancing Local Diagnostic Industry through One-stop IVD Solutions

Fapon, a global leading life sciences company, is showcasing its comprehensive one-stop IVD solutions and sharing the latest industry insights with...

Fapon Highlights Innovative IVD Total Solutions and Localization Services at MEDICA 2024

Fapon Highlights Innovative IVD Total Solutions and Localization Services at MEDICA 2024

Fapon, a global leading life sciences company, is excited to participate in the upcoming MEDICA 2024 International Trade Fair, which will take place...

المزيد من الإصدارات من هذا المصدر

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Medical Equipment

Medical Equipment

Artificial Intelligence

Artificial Intelligence

المزيد من البيانات الصحفية في مواضيع ذات صلة

Contact PR Newswire

  • +971 (0) 4 368 1644
    from 8 AM - 5:30 PM GMT

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+971 (0) 4 368 1644
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.